site stats

Biotheranostics stock

Web2 days ago · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ... WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients.

San Diego Laboratory Agrees to Pay $2 Million to Settle False …

WebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for … WebDec 10, 2024 · San Diego, CA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announced today that several abstracts featuring updates on ongoing resea... sharex language https://riflessiacconciature.com

Biotheranostics, Inc., A Hologic Company LinkedIn

WebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation … WebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancers ... WebContact Information. 9640 Towne Centre Dr #200. San Diego, CA 92121. Visit Website. Email this Business. (877) 886-6739. sharex how to take a scrolling screenshot

Biotheranostics, Inc., A Hologic Company LinkedIn

Category:Hologic to buy privately held cancer-test maker for $230 million

Tags:Biotheranostics stock

Biotheranostics stock

Biotheranostics - Overview, News & Competitors ZoomInfo.com

WebJan 8, 2024 · Hologic, Inc. (. HOLX Quick Quote. HOLX - Free Report) recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests ... WebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected]

Biotheranostics stock

Did you know?

WebBioTheranostics General Information. Description. Developer of commercial-stage molecular diagnostics intended to guide cancer treatment. The company develops and … WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in …

Web(See HOLX stock analysis on TipRanks) Following the deal, Needham analyst Michael Matson said, “HOLX is a leader in the infectious disease testing market and we believe … WebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women and their doctors decide if extending hormonal therapy 5 more years (for a total of 10 years of …

WebJan 19, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. ... The bank suspended its … WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing …

WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ...

WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. … pop out bed for enclosed trailerWebJan 5, 2024 · BioTheranostics's latest funding round was a Acquired for on January 5, 2024. BioTheranostics's valuation in January 2016 was $94.01M. BioTheranostics's … sharex medicalWebJan 6, 2024 · Ana Baraulia - stock.adobe.com. The Marlborough, MA-based company said it would acquire Biotheranostics for $230 million. Omar Ford Jan 06, 2024. ... Biotheranostics generated about $33 … sharex loginWebHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. share xlsx file with google sheetsWebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth … pop out birthday card ideaspop out bingo cardsWebMar 11, 2024 · News for Hologic Stock (HOLX) Hologic Stock Sees Composite Rating Climb To Lofty 96. Investors Business Daily • 03/17/21. Top-Rated Stocks: Hologic Sees Composite Rating Climb To 96 ... Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market. Business Wire • 02/22/21. Is Hologic … pop out birthday card template